Institutional Ownership Rocket Pharmaceuticals, Inc. (RCKT)
This table provides information about the institutional ownership of Rocket Pharmaceuticals, Inc. (RCKT). We have compiled data on the 243 institutions that hold shares in the stock, with a total of 94.8 Million shares, which have been reported (via 13F filing form) to have a value of $744 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Bank Of America Corp
Charlotte, NC |
Feb 14, 2025 Q4 2024 |
224,311
shares
|
$1.76 Million
0.0% of portfolio
|
Q4 2024
Reduced 44.77%
|
|
Ikarian Capital, LLC
Dallas, TX |
Feb 14, 2025 Q4 2024 |
221,911
shares
|
$1.74 Million
0.46% of portfolio
|
Q4 2024
Added 12.59%
|
|
Walleye Capital LLC
Plymouth, MN |
Feb 13, 2025 Q4 2024 |
220,142
shares
|
$1.73 Million
0.01% of portfolio
|
Q4 2024
Added 59.06%
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Feb 13, 2025 Q4 2024 |
218,519
shares
|
$1.72 Million
0.0% of portfolio
|
Q4 2024
New holding
|
|
Adar1 Capital Management, LLC
Austin, TX |
Feb 13, 2025 Q4 2024 |
211,400
shares
|
$1.66 Million
0.53% of portfolio
|
Q4 2024
Added 4816.28%
|
|
Mirador Capital Partners LP
|
Apr 08, 2025 Q1 2025 |
203,829
shares
|
$1.6 Million
0.29% of portfolio
|
Q1 2025
Added 141.13%
|
|
Ovata Capital Management LTD
|
Feb 12, 2025 Q4 2024 |
200,000
shares
|
$1.57 Million
2.45% of portfolio
|
Q4 2024
New holding
|
|
Exodus Point Capital Management, LP
New York, NY |
Feb 12, 2025 Q4 2024 |
189,879
shares
|
$1.49 Million
0.02% of portfolio
|
Q4 2024
Added 189.37%
|
|
Harbor Capital Advisors, Inc.
|
Apr 14, 2025 Q1 2025 |
178,236
shares
|
$1.4 Million
0.05% of portfolio
|
Q1 2025
Added 7.94%
|
|
Mirae Asset Global Etfs Holdings Ltd.
Central, K3 |
Feb 14, 2025 Q4 2024 |
177,548
shares
|
$1.39 Million
0.01% of portfolio
|
Q4 2024
Added 2.3%
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
167,716
shares
|
$1.32 Million
0.0% of portfolio
|
Q2 2024
Added 4.8%
|
|
Synovus Financial Corp
Columbus, GA |
Feb 13, 2025 Q4 2024 |
163,893
shares
|
$1.29 Million
0.03% of portfolio
|
Q4 2024
Added 71.61%
|
|
Td Asset Management Inc
|
May 07, 2025 Q1 2025 |
162,710
shares
|
$1.28 Million
0.0% of portfolio
|
Q1 2025
Reduced 8.82%
|
|
Exome Asset Management LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
159,552
shares
|
$1.25 Million
1.51% of portfolio
|
Q4 2024
New holding
|
|
Rafferty Asset Management, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
156,260
shares
|
$1.23 Million
0.01% of portfolio
|
Q4 2024
Added 21.39%
|
|
International Biotechnology Trust PLC
London, X0 |
Nov 14, 2023 Q3 2023 |
156,000
shares
|
$1.22 Million
1.08% of portfolio
|
Q2 2023
Added 147.62%
|
|
Swiss National Bank
Zurich, V8 |
Feb 10, 2025 Q4 2024 |
153,700
shares
|
$1.21 Million
0.0% of portfolio
|
Q4 2024
Added 23.35%
|
|
Manufacturers Life Insurance Company, The
Toronto, A6 |
Feb 14, 2025 Q4 2024 |
152,489
shares
|
$1.2 Million
0.0% of portfolio
|
Q4 2024
Added 0.13%
|
|
New Leaf Venture Partners, L.L.C.
New York, NY |
Feb 13, 2025 Q4 2024 |
150,706
shares
|
$1.18 Million
2.55% of portfolio
|
Q2 2024
Added 27.46%
|
|
Efg Asset Management (North America) Corp.
|
Feb 11, 2025 Q4 2024 |
145,629
shares
|
$1.14 Million
0.26% of portfolio
|
Q4 2024
Reduced 40.42%
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Feb 14, 2025 Q4 2024 |
139,572
shares
|
$1.1 Million
0.0% of portfolio
|
Q4 2024
Added 16.67%
|
|
Acuta Capital Partners, LLC
Belmont, CA |
Feb 14, 2025 Q4 2024 |
134,500
shares
|
$1.06 Million
2.4% of portfolio
|
Q4 2024
Reduced 29.21%
|
|
Nordea Investment Management Ab
Stockholm, V7 |
Jan 06, 2025 Q4 2024 |
127,270
shares
|
$999,069
0.0% of portfolio
|
Q4 2024
Added 0.4%
|
|
Citigroup Inc
|
Feb 12, 2025 Q4 2024 |
123,415
shares
|
$968,807
0.0% of portfolio
|
Q4 2024
Added 139.66%
|
|
Torray LLC
|
Feb 06, 2025 Q4 2024 |
122,095
shares
|
$958,445
0.23% of portfolio
|
Q4 2024
Added 66.29%
|